![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 520 800 $ al 30/09/2026
Mr. Troy A. Ignelzi is an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Contineum Therapeutics, Inc., a Chief Financial Officer at Rapport Therapeutics, Inc., an Executive Advisor at Sofinnova Investments, Inc. and an Independent Director at Abivax SA. He is on the Board of Directors at Harmony Biosciences Holdings, Inc., Contineum Therapeutics, Inc. and Abivax SA.
Mr. Ignelzi was previously employed as an Independent Director by CinCor Pharma, Inc., a Chairman by Vedanta Biosciences, Inc., a Chief Financial Officer by Karuna Therapeutics, Inc., a Chief Financial & Accounting Officer by scPharmaceuticals, Inc., a Chief Financial Officer by Juventas Therapeutics, Inc., a Senior VP-Operations & Business Development by PharmaLex GmbH, a Vice President by Esperion Therapeutics, Inc., and a VP-Business Development & Strategic Planning by InSys Therapeutics, Inc. /Old/.
He received his undergraduate degree from Ferris State University (Michigan).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/10/2026 | 15.500 ( 0,03 % ) | 520 800 $ | 30/09/2026 | |
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABIVAX | Director/Miembro de la Junta | 11/07/2023 |
| RAPPORT THERAPEUTICS, INC. | Director Financiero/CFO | 01/11/2023 |
| CONTINEUM THERAPEUTICS, INC. | Director/Miembro de la Junta | 20/05/2024 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Miembro de la Junta | 02/04/2026 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Inversor de Capital Privado | 01/11/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| KARA THER | Director Financiero/CFO | 29/09/2023 |
| CINCOR PHARMA, INC. | Director/Miembro de la Junta | 24/02/2023 |
| SCPHARMACEUTICALS INC. | Director Financiero/CFO | 28/02/2019 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. BiotechnologyHealth Technology Develops regenerative and gene therapies to treat advanced cardiovascular diseases | Director Financiero/CFO | 01/02/2016 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. BiotechnologyHealth Technology Develops regenerative and gene therapies to treat advanced cardiovascular diseases | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
